Review

Targeted protein degradation: bridging chemical biology and clinical translation.

Yu-bo Zhang Junwei Fu Yue Liu Ruilin Wu Yan-Ting Liang Wen-Han Zhang T. Yuan Hong Zhu Qiao‐jun He Bo Yang

Jul 2026 · Acta Pharmacologica Sinica · 0 citations · 168 references

Medicine

TL;DR

An overview of the developmental trajectory of the TPD field is provided and how diverse modalities can be leveraged to address intracellular, membrane-associated, and extracellular protein targets are discussed.

DOI PubMed Semantic Scholar

View source

Similar papers

Review Aug 2026

Targeted protein degradation: mechanistic diversity, therapeutic expansion, and clinical translation.

This review provides a roadmap for translating TPD into transformative therapies and outlines key challenges including novel E3 ligase ligand discovery, tissue selectivity, and acquired resistance, and discusses how covalent fragment screening, artificial intelligence, and expanded E3 ligase repertoires will advance next-generation degraders to fulfill the promise of event-driven pharmacology.

Caiyu Wang, Zhibin Guo, Yufei Liu et al. · International journal of pha... · 0 citations

Review Open access Jul 2026

TARGETED PROTEIN DEGRADATION WITH PROTACS IN CANCER THERAPY: MECHANISMS, CLINICAL ADVANCES, CHALLENGES, AND FUTURE PERSPECTIVES

This thorough analysis investigates the molecular basis of PROTAC technology, tracking its progression from an elegant intellectual notion to a clinically approved treatment platform and provides a detailed survey of the current clinical landscape.

N. Vijaya Lakshmi Reddy, M. Sarika, V. Deepika et al. · International Journal of Adv... · 0 citations

Review Aug 2026

Beyond the ATP-binding pocket: emerging strategies in kinase targeting from allosteric inhibition to targeted protein degradation.

The structural and medicinal chemistry principles underlying (i) allosteric inhibition and (ii) proximity-induced degradation are summarized, with an emphasis on design logic, structure-activity relationships, and key liabilities in the beyond rule of five space.

Mei Zhou, Linshan Li, Xiaojuan Tang et al. · Future Medicinal Chemistry · 0 citations

Review Open access Aug 2026

PROTAC-Based Strategies in Neurodegenerative Diseases: Challenges and Perspectives

This review summarizes recent advances in chemical protein degradation strategies for neurodegenerative disorders and highlights potential future perspectives of multifunctional PROTACs for therapeutic development.

Pasquale Degennaro, Imane Ghafir El Idrissi, Rosa Purgatorio et al. · Pharmaceuticals · 0 citations

Review Open access 2026

Nano-targeted protein degradation: Ushering in a new era of protein degradation therapeutics

The core mechanisms of Nano-TPD, encompassing targeted delivery, intracellular trafficking, stimuli-triggered release, and enhanced protein degradation via UPS or lysosomal pathways, are systematically elaborated.

Miaoxizi Luo, Jiaqi Ma, Chuan Hu et al. · The Innovation Drug Discover... · 0 citations

Aug 2026

Post-translational chemical modification of E3 ligase for efficient target protein degradation.

This work reports the first ligand-directed chemical strategy that converts transient PROTAC-mediated ternary complex formation into binary target recognition via post-translational chemical modification of an E3 ligase, and believes it could provide a platform for next-generation targeted protein degraders to overcome the current limitation of PROTAC approach.

Eunbin Park, Jinjoo Jung, Gangasani Jagadeesh Kumar et al. · Bioorganic chemistry (Print) · 0 citations